Advertisement
Advertisement

LUNG

LUNG logo

Pulmonx Corporation Common Stock

1.39
USD
Sponsored
+0.11
+8.59%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

1.38

-0.01
-0.43%

LUNG Earnings Reports

Positive Surprise Ratio

LUNG beat 22 of 23 last estimates.

96%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$22.85M
/
-$0.28
Implied change from Q1 26 (Revenue/ EPS)
+10.99%
/
-15.15%
Implied change from Q2 25 (Revenue/ EPS)
-4.24%
/
-26.32%

Pulmonx Corporation Common Stock earnings per share and revenue

On Apr 29, 2026, LUNG reported earnings of -0.33 USD per share (EPS) for Q1 26, beating the estimate of -0.33 USD, resulting in a 0.96% surprise. Revenue reached 20.59 million, compared to an expected 20.84 million, with a -1.22% difference. The market reacted with a +6.67% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 22.85 million USD, implying an decrease of -15.15% EPS, and increase of 10.99% in Revenue from the last quarter.
FAQ
For Q1 2026, Pulmonx Corporation Common Stock reported EPS of -$0.33, beating estimates by 0.96%, and revenue of $20.59M, -1.22% below expectations.
The stock price moved up 6.67%, changed from $1.20 before the earnings release to $1.28 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 8 analysts, Pulmonx Corporation Common Stock is expected to report EPS of -$0.28 and revenue of $22.85M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement